» Articles » PMID: 15696568

Cost-utility and Cost-effectiveness Analyses of a Long-term, High-intensity Exercise Program Compared with Conventional Physical Therapy in Patients with Rheumatoid Arthritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2005 Feb 8
PMID 15696568
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the cost utility and cost effectiveness of long-term, high-intensity exercise classes compared with usual care in rheumatoid arthritis (RA) patients.

Methods: RA patients (n = 300) were randomly assigned to either exercise classes or UC; followup lasted for 2 years. Outcome measures were quality-adjusted life years (QALYs) according to the EuroQol (EQ-5D), Short Form 6D (SF-6D), and a transformed visual analog scale (VAS) rating personal health; functional ability according to the Health Assessment Questionnaire (HAQ) and McMaster Toronto Arthritis Patient Preference Interview (MACTAR); and societal costs.

Results: QALYs in both randomization groups were similar according to the EQ-5D and SF-6D, but were in favor of usual care according to the VAS (annual difference 0.037 QALY; 95% confidence interval [95% CI] 0.002, 0.069). Functional ability was similar according to the HAQ, but in favor of the exercise classes according to the MACTAR (annual difference 2.9 QALY; 95% CI 0.9, 4.9). Annual medical costs of the exercise program were estimated at 780 per participating patient (1 approximately $1.05). The increase per patient in total medical costs of physical therapy was estimated at 430 (95% CI 318, 577), and the increase in total societal costs at 602 (95% CI -490, 1,664). For societal willingness-to-pay equal to 50,000 per QALY, usual care had better cost utility than exercise classes, and significantly so according to the VAS.

Conclusion: From a societal perspective and without taking possible preventive health effects into account, long-term, high-intensity exercise classes provide insufficient improvement in the valuation of health to justify the additional costs.

Citing Articles

Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.

Teuwen M, van Weely S, van den Ende C, van Wissen M, Vliet Vlieland T, Peter W Scand J Rheumatol. 2024; 54(2):87-97.

PMID: 39351606 PMC: 11854037. DOI: 10.1080/03009742.2024.2392360.


Cost-Effectiveness of Treatments for Musculoskeletal Conditions Offered by Physiotherapists: A Systematic Review of Trial-Based Evaluations.

Baumbach L, Feddern W, Kretzler B, Hajek A, Konig H Sports Med Open. 2024; 10(1):38.

PMID: 38613739 PMC: 11016054. DOI: 10.1186/s40798-024-00713-9.


Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.

Teuwen M, Vliet Vlieland T, van Weely S, Schoones J, Rausch Osthoff A, Juhl C Rheumatol Int. 2023; 44(1):25-39.

PMID: 38030947 DOI: 10.1007/s00296-023-05502-3.


Economic Evaluation of Glucosamine in Knee Osteoarthritis Treatments in Vietnam.

Vo N, Che U, Ngo T, Bui T Healthcare (Basel). 2023; 11(18).

PMID: 37761699 PMC: 10531128. DOI: 10.3390/healthcare11182502.


Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention in people with inflammatory arthritis: study protocol of the Physiotherapy WORKs trial.

Bakker N, van Weely S, Hutting N, Heerkens Y, Engels J, Staal J BMC Rheumatol. 2023; 7(1):31.

PMID: 37730637 PMC: 10510245. DOI: 10.1186/s41927-023-00357-4.